Psychiatric Epidemiology and Burden of Disease (PEABOD)

PSYCHIATRIC EPIDEMIOLOGY AND BURDEN OF DISEASE

Research Streams

Staff Profiles

AlizeAlize J. Ferrari, BPsySc (Hons)
Research Associate

Alize is a PEABOD research associate and leads the work undertaken by the group. She holds affiliate positions with the School of Population Health at the University of Queensland and the Institute for Health Metrics and Evaluation at the University of Washington. In addition to overseeing the work undertaken by PEABOD, Alize’s expertise relates to the epidemiology, burden, risk factors, and outcomes of mood disorders. In the Global Burden of Disease Studies, Alize is responsible for the systematic review, data extraction, and epidemiological modelling of major depressive disorder, dysthymia, bipolar disorder, anxiety disorders, and cannabis dependence. She has also provided expertise to the Australian Burden of Disease Study currently underway and is an investigator on a Kinsman Fellowship grant awarded to quantify the burden of postnatal depression in Australia and New Zealand. She has presented at a number of domestic and international conferences including the World Mental Health Survey Meeting in Belgium. She has recently submitted her PhD which focused on formulating an epidemiological profile for major depressive disorder, investigating the global distribution, burden, risk factors, and outcomes of this disorder.

 

 

Holly

Holly E. Erskine, BPsySc (Hons)
Research Associate

Holly is a PEABOD research associate and holds affiliate positions with the School of Population Health at the University of Queensland and the Institute for Health Metrics and Evaluation at the University of Washington. Her focus within PEABOD is the epidemiology, burden, and outcomes associated with mental disorders of childhood with a particular focus on conduct disorder and ADHD. In the Global Burden of Disease Studies, Holly is responsible for the systematic review, data extraction, and epidemiological modelling of conduct disorder, ADHD, autism, Asperger’s syndrome, anorexia nervosa, and bulimia nervosa. She has provided expertise to the Australian Young Minds Matter survey and has presented at a number of domestic and international conferences including the most recent IFPE Congress in Leipzig. Holly is in the final year of her PhD which focuses on the global epidemiology and burden of conduct disorder and ADHD.

 

 

Fiona

Fiona J. Charlson, BPharm, MPH
Research Associate

Fiona is a PEABOD research associate and holds affiliate positions with the Schoolof Population Health at the University of Queensland and the Institute for Health Metrics and Evaluation at the University of Washington. She received her undergraduate degree at the University of Queensland and has completed a Masters in International Public Health at the University of Sydney. Her original training was as a pharmacist and she has 18 years of experience including work as a community pharmacist in Australia and New Zealand, project pharmacist for an international NGO in West Africa, and a referral pharmacist for Medecins Sans Frontieres’ ‘Campaign for Access to Essential Medicines’ in Geneva, Switzerland. Fiona began her work on the Global Burden of Disease Study at the National Drug and Alcohol Research Centre at University of New South Wales in 2007 where she also assisted the Reference Group to the United Nations on HIV/AIDS in injecting drug users. Currently, Fiona is responsible for the systematic review, data extraction, and epidemiological modelling of schizophrenia, amphetamine dependence, cocaine dependence, opioid dependence for the Global Burden of Disease Study.  She is currently in the final year of her PhD which relates to mental disorders in conflict-affected populations.

Publications